Use of Biologics and Stem Cells in Equine Ophthalmology.

This research paper discusses the potential benefits of regenerative therapy and biologics like blood-derived products, stem cells, and amniotic membrane grafts in treating ocular surface and intraocular diseases in horses.

Introduction to Biologics and Regenerative Therapy

• The research paper explores the application of biologics and regenerative therapies in the field of equine ophthalmology. Regenerative therapy refers to the process of replacing or “regenerating” human cells, tissues, or organs to restore or establish the normal function of a specific body part.
• Biologics, on the other hand, are medicines made from substances found in living organisms and can include components like proteins, nucleic acids, or living entities such as cells and tissues. In this research, the utilization of these two advanced medical applications promises to pave the way for a more effective treatment of eye diseases in horses.

Treatment of Ocular Surface Diseases

• Ocular surface diseases include ailments affecting the surface of the eye like corneal ulceration or immune-mediated keratitis. These problems can lead to pain, vision impairment, or even blindness if untreated.
• Through the use of biologics such as blood-derived products like serum or platelet-rich plasma, these diseases could be treated more efficiently. This option may be particularly beneficial for ulcerative and chronic keratitis in horses.

Amniotic Membrane Grafts

• Another potential treatment discussed in this study involves the use of amniotic membrane grafts for ocular diseases. The amniotic membrane is the innermost layer of the placenta and plays a key role in fetal support during pregnancy.
• Research indicates that amniotic membrane grafts may facilitate the healing process and reduce inflammation and scarring, making them a promising option for treating ocular surface diseases.

Stem Cells and Gene Therapy for Intraocular Diseases

• Intraocular diseases, like equine recurrent uveitis, affect the interior parts of the eye. Biologics and regenerative therapies, specifically stem cells and gene therapy, offer a new avenue of treatment for these blinding diseases.
• Stem cells are capable of dividing and changing into other cell types, which could potentially replace damaged cells within the eye. Gene therapy, meanwhile, involves altering the genes within a person’s or animal’s cells to treat or prevent disease.
• These treatment options could provide practical, effective, and long-term therapy, providing a possible good quality of life for horses afflicted with these diseases.